Cognition Therapeutics, Inc. (CGTX)
NASDAQ·Healthcare·Biotechnology
$1.29
+0.39%
Mkt Cap $94.19M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | — | — | — | -$0.06 | -$0.02 | +66.67% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.07 | -$0.06 | +14.29% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.12 | -$0.11 | +8.33% | — | — |
| Q2 2025 May 7, 2025 | — | — | — | -$0.12 | -$0.14 | -16.67% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.16 | -$0.17 | -6.25% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.24 | -$0.25 | -4.17% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.22 | -$0.18 | +18.18% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.23 | -$0.27 | -17.39% | — | — |
| Q1 2024 Mar 26, 2024 | — | $372.00K | — | -$0.38 | -$0.27 | +28.95% | — | — |
| Q4 2023 Nov 2, 2023 | — | — | — | -$0.31 | -$0.22 | +29.03% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.25 | -$0.16 | +36.00% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$0.17 | -$0.21 | -23.53% | — | — |
| Q1 2023 Mar 23, 2023 | — | — | — | -$0.49 | -$0.20 | +59.18% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.55 | -$0.29 | +47.27% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.31 | -$0.25 | +19.35% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$0.27 | -$0.17 | +37.04% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$0.26 | -$11.74 | -4415.38% | — | — |
| Q4 2021 Nov 17, 2021 | — | — | — | -$0.57 | -$8.12 | -1324.56% | — | — |
| Q4 2021 Oct 8, 2021 | — | — | — | — | -$0.07 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | $0.01 | — | — | — |